MKMohamed Gomaa Kamel

Mohamed Gomaa Kamel

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Mohamed Gomaa Kamel has a total of 210 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Journal update monthly top five

    by Kieran Johnstone, Mohamed Gomaa Kamel, Johnathan Goves, Hanya El-Geresy, Richard Mifsud, Alex Novak, David Metcalfe, Liam Barrett

  • Journal update monthly top five

    by Sarah Wilson, Mohomed Ashraf, Karen Chivers, Trent Crawford Allen, Charles Oyedepo, Akhil Cheeran John, Osama Akrama, Mohamed Gomaa Kamel, Gabrielle Prager

  • Open Access

    New biomarkers for liver involvement by dengue infection in adult Vietnamese patients: a case-control study

    by Nguyen Thi Cam Huong, Nguyen Phuong Hai, Chau Van Khanh, Mohamed Gomaa Kamel, Nguyen Van Vinh Chau, Nguyen Thanh Truong, Nguyen Thanh Vinh, Randa Elsheikh, Abdelrahman M Makram, Aya Elsheikh, et al.

    Liver injury with marked elevation of aspartate aminotransferase enzyme (AST) is commonly observed in dengue infection. To understand the pathogenesis of this liver damage, we compared the plasma levels of hepatic specific, centrilobular predominant enzymes (glutamate dehydrogenase, GLDH; glutathione S transferase-α, αGST), periportal enriched 4-hydroxyphenylpyruvate dioxygenase (HPPD), periportal predominant arginase-1 (ARG-1), and other non-specific biomarkers (paraoxonase-1, PON-1) in patients with different outcomes of dengue infection. This hospital-based study enrolled 87 adult dengue patients, stratified into three groups based on plasma AST levels (< 80, 80–400, > 400 U/L) in a 1:1:1 ratio (n = 40, n = 40, n = 40, respectively. The new liver enzymes in the blood samples from the 4th to 6th days of their illness were measured by commercial enzyme-linked immunosorbent assay (ELISA) or colorimetric kits. Based on the diagnosis at discharge days, our patients were classified as 40 (46%) dengue without warning signs (D), 35 (40.2%) dengue with warning signs (DWS), and 11 (12.6%) severe dengue (SD) with either shock (two patients) or AST level over 1000 U/L (nine patients), using the 2009 WHO classification. The group of high AST (> 400 U/L) also had higher ALT, GLDH, ARG-1, and HPPD than the other groups, while the high (> 400 U/L) and moderate (80–400 U/L) AST groups had higher ALT, αGST, ARG-1, and HPPD than the low AST group (< 80 U/L). There was a good correlation between AST, alanine aminotransferase enzyme (ALT), and the new liver biomarkers such as GLDH, αGST, ARG-1, and HPPD. Our findings suggest that dengue-induced liver damage initiates predominantly in the centrilobular area toward the portal area during the dengue progression. Moreover, these new biomarkers should be investigated further to explain the pathogenesis of dengue and to validate their prognostic utility. Arginase-1, α-glutathione S transferase, and 4-hydroxyphenylpyruvate dioxygenase levels were significantly associated with dengue severity and can serve as good prognostic predictors for liver injury. Our findings suggest that dengue-induced liver damage initiates predominantly in the centrilobular area toward the portal area during the dengue progression.


  • Open Access

    Comment on: A novel dominant-negative PD-1 armored anti-CD19 CAR T cell is safe and effective against refractory/relapsed B cell lymphoma

    by Firas Baidoun, Zahi Merjaneh, Fatma Abd-Elshahed Abd-Elhay, Mohamed Gomaa Kamel


  • The diagnostic and prognostic role of neutrophil-to-lymphocyte ratio in COVID-19: a systematic review and meta-analysis

    by Ahmed Abdelaal Ahmed Mahmoud M. Alkhatip, Mohamed Gomaa Kamel, Mohamed Khaled Hamza, Ehab Mohamed Farag, Hany Mahmoud Yassin, Mohamed Elayashy, Amr Ahmed Naguib, Mohamed Wagih, Fatma Abd-Elshahed Abd-Elhay, Haytham Zien Algameel, et al.

    The world urgently requires surrogate markers to diagnose COVID-19 and predict its progression. The severity is not easily predicted via currently used biomarkers. Critical COVID‐19 patients need t...


  • Open Access

    Epidemiologic Features and Clinical Course of COVID-19: A Retrospective Analysis of 19 Patients in Germany

    by Sara Elgamasy, Eman Elsayed Sakr, Mohamed Gomaa Kamel, Sherief Ghozy, Ghadeer Gamal Elsayed, Mostafa Mahmoud Fahmy, Ahmed Ghazy, Mohamed Maged Nagaty Ibrahim, Mostafa Ebraheem Morra

    Background: SARS-coronavirus-2 causes coronavirus disease-19 (COVID-19). Materials & methods: We here report epidemiology; clinical, radiological and laboratory characteristics; and outcomes of COV...


  • Using the primary site as a prognostic tool for nodal mantle cell lymphoma: a SEER-based study

    by Mohamed Gomaa Kamel, Amr Ehab El-Qushayri, Ahmed Kamal Sayed, Nguyen Tien Huy

    Background:Nodal mantle cell lymphoma (NMCL) has a worse survival than extra-nodal mantle cell lymphoma.Materials & methods:A cohort study was conducted to evaluate the primary site role as a mortality predictor using data from 1983 to 2011 from the Surveillance, Epidemiology, and End Results (SEER) database.Results:Most patients had NMCL in multiple regions (71.9%). There was a significantly increased incidence of NMCL cases over years with 83.2% of them occurred between 1998 and 2011. The mean survival was 52.9 months with overall survival/cancer-specific survival rate of 29.2/42.9%, respectively. Lymph nodes of intrathoracic and multiple regions had a worse overall survival while the head, face and neck, intra-abdominal, pelvic, inguinal region and leg as well as multiple regions had worse cancer-specific survival.Conclusion:NMCL primary site can serve as a prognostic factor. We encourage adding it to MCL International Prognostic Index.


  • Possible therapeutic agents for COVID-19: a comprehensive review

    by Khaled Mosaad Elhusseiny, Fatma Abd-Elshahed Abd-Elhay, Mohamed Gomaa Kamel

    Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has emerged in China. There are no available vaccines or antiviral drugs for COVID-19 patients. Herein, we represented possible therapeutic agents that may stand as a potential therapy against COVID-19. We searched PubMed, Google Scholar, and clinicaltrials.gov for relevant papers. We showed some agents with potentially favorable efficacy, acceptable safety as well as good pharmacokinetic profiles. Several therapies are under assessment to evaluate their efficacy and safety for COVID-19. However, some drugs were withdrawn due to their side effects after demonstrating some clinical efficacy. Indeed, the most effective therapies could be organ function support, convalescent plasma, anticoagulants, and immune as well as antiviral therapies, especially anti-influenza drugs due to the similarities between respiratory viruses regarding viral entry, uncoating, and replication. We encourage giving more attention to favipiravir, remdesivir, and measles vaccine. A combination, at least dual or even triple therapy, of the aforementioned efficacious and safe therapies is greatly recommended for COVID-19. Further, patients should have a routine assessment for their coagulation and bleeding profiles as well as their inflammatory and cytokine concentrations.


  • First case of focal epilepsy associated with SARS‐coronavirus‐2

    by Sara Elgamasy, Mohamed Gomaa Kamel, Sherief Ghozy, Adham Khalil, Mostafa Ebraheem Morra, Sheikh Mohammed Shariful Islam

    A healthy patient presented to Klinikum Altmühlfranken Weißenburg Hospital, Germany, with two morning attacks of painful muscle spasm in the left upper and lower limbs, without altered consciousness. Full examinations, radiological imaging, electroencephalography, lumbar puncture, and autoimmune profile were either normal or not consistent with patient's complaint. Subsequent epileptic episodes were observed on admission day and the following days; thus, the patient was diagnosed with focal epilepsy. The patient started to develop a fever and severe cough on day 4, and SARS‐coronavirus‐2 was confirmed through a nasopharyngeal swap. She received anticonvulsants and symptomatic treatments and completely recovered. This report emphasizes the potential nervous system involvement in severe acute respiratory syndrome‐coronavirus‐2 pathogenesis.


  • Open Access

    Epidemiologic Features and Clinical Course of COVID-19: a Retrospective Analysis of 19 Patients in Germany

    by Sara Elgamasy, Eman Elsayed Sakr, Mohamed Gomaa Kamel, Sherief Ghozy, Ghadeer Gamal Awad, Mostafa Mahmoud Fahmy, Ahmed Ghazy, Mohamed Maged Nagaty, Mostafa Ebraheem Morra

    Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes coronavirus disease-19 (CoVID-19). The virus has exhibited unprecedented human to human transmission and progressed into a pandemic over a short duration. Aim To report the epidemiology; clinical, radiological, and laboratory characteristics; and outcome of SARS-CoV-2 infection in 19 patients in Germany. Methods Retrospective analysis of 19 patients contracting SARS-CoV-2 infection confirmed by PCR in Germany between March 1, 2020 and March 31, 2020. Results In 19 PCR-confirmed SARS-Cov-2 virus infection (median age 69 years; 12 (63%) males), the most common presentations were Fever (79%), cough (79%), fatigue (79%), and dyspnea (42%). The most common comorbidities were hypertension (47%), hypothyroidism (32%), and cardiac diseases (32%). According to chest X-ray, 15 (79%) of patients had abnormal chest X-rays; of these, 13 had bilateral chest infiltrates and two had unilateral infiltrates. Lactate dehydrogenase and C-reactive protein (CRP) were elevated in all patients at baseline investigations; 343 U/L (169-931 U/L) and 8 mg/dL (1-17 mg/dL), respectively. Of the 19 cases, 13 (68.4%) recovered and discharged, 9 (47.3%) needed ICU admission, and 4 (21.1%) cases died. Conclusion Among the 19 patients diagnosed with SARS-CoV-2, mild respiratory tract infections symptoms were frequently reported. Some patients required supplemental oxygen and had variable clinical outcomes following supportive and antibiotic treatments. These findings may contribute to the development of more effective strategies of infection control.